Search

Search Constraints

You searched for: Author/Creator Nachury, Maria

Search Results

21. Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID. Issue 9 (September 2022)

22. Motivation to pursue anti-TNFα treatment in patients with Crohn's disease – the SPACE motivation study. Issue 9 (September 2020)

23. Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis. Issue 10 (October 2018)

24. Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab. Issue 10 (October 2017)

25. Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Issue 4 (April 2021)

26. Prevalence of anti-TNF contraindications in Crohn's disease: A cross-sectional survey from the GETAID. Issue 10 (October 2022)

27. Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Issue 6 (19th November 2022)

28. Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. Issue 6 (June 2016)

29. Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study. Issue 1 (March 2023)

30. Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model. Issue 1 (31st March 2022)